Recipharm

Recipharm, founded in Sweden in 1995, has grown to become a leading Contract Development and Manufacturing Organization (CDMO). Headquartered in Jordbro, with approximately 3,500 employees, Recipharm's B shares (RECI B) are listed on Nasdaq Stockholm. For over 20 years, Recipharm has been dedicated to supporting pharmaceutical companies in bringing products from early development to commercial manufacturing. Throughout the product lifecycle, Recipharm serves its clients, consistently delivering innovative solutions.